Cite Filings / EWTX / 0001558370-24-005906
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEFA14A

Proxy Materials

Edgewise Therapeutics, Inc. · Filed 2024-04-26 · Acc 0001558370-24-005906

Documents 1

  • DEFA14A Proxy Materials , tmb-20240424xdefa14a.htm

Around this filing

  • 2024-05-07 DEFA14A Proxy Materials
  • 2024-05-03 4 Chief Scientific Officer sold 1,576 shares at $18.91 ($29,802)
  • 2024-05-03 4 CMO sold 3,682 shares at $18.91 ($69,627)
  • 2024-05-03 4 President and CEO sold 3,152 shares at $18.91 ($59,604)
  • 2024-04-26 DEFA14A Proxy Materials
  • 2024-04-26 DEF 14A Proxy Statement
  • 2023-04-28 DEFA14A Proxy Materials

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tmb-20240424xdefa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…